Immediate Implant Placement With Provisionalization Using Different Bone Grafts as a Space Filling Material in the Maxillary Esthetic Zone

Sponsor
Mohamed tarek mohamed youssif omar (Other)
Overall Status
Unknown status
CT.gov ID
NCT03741036
Collaborator
Cairo University (Other)
30
2
3
8.6
15
1.7

Study Details

Study Description

Brief Summary

compare autogenous bone graft, xenograft and nanohydroxyapatite in immediate implant w placement in maxillary esthetic zone with provisionalization

Condition or Disease Intervention/Treatment Phase
  • Procedure: Autogenous bone graft as space filling in immidiate implant placment
  • Procedure: Deprotinized bovien as space filling in immidate implant placement
  • Procedure: Nano-hydroxiapatite alloplast in immidiate implant placement
N/A

Detailed Description

Placement of implants into extraction sockets targets the maintenance of peri implant hard and soft tissue structures and the support of a natural and esthetic contour. The main advantages of immediate implant insertion in comparison with delayed implant placement protocols are as follows: a reduced treatment time, less number of sessions, and, thus, the less invasive procedure. This study examines the clinical performance (survival rate, marginal bone levels and Pink Esthetic Score [PES]) of OsseoSpeed™ implants placed into extraction sockets with immediate provisionalization in the anterior maxilla after a follow-up of at least 12 months.

The removal of teeth results inevitably in both horizontal and vertical changes of hard and soft tissue dimensions.

Clinical research has shown that the loss of volume in the extraction sockets is high: the biggest bone volumetric changes take place during the first 12 months from the dental extraction, with a reduction of bone volume of 50%, of which 2/3 (30%) are within the first 3 months.

Nowadays to get success in postextraction implantology means managing the early and irreversible alveolar bone dimensional changes following tooth extraction, in order to minimize the negative effects on the aesthetics final.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Immediate Implant Placement With Provisionalization Using Autogenous Bone Graft Particulates vs Deproteinized Bovine Bone vs Nano-hydroxyapatite Alloplast as a Space Filling Material in the Maxillary Esthetic Zone
Anticipated Study Start Date :
Nov 27, 2018
Anticipated Primary Completion Date :
Jul 27, 2019
Anticipated Study Completion Date :
Aug 17, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: autogenous bone graft as a space filling material

Autogenous bone from sub mental bone had been grafted in jumping gap between implant and freshely extracted socket

Procedure: Autogenous bone graft as space filling in immidiate implant placment
The selected patients will be informed of the nature of the research work and informed consent will be obtained (immediate implant placement grafting with autogenous bone graft) Patients will be subjected to CBCT (diagnostic for upper arch). Local anesthesia will be given to the patient. Scrubbing and draping of the patient will be carried out in a standard fashion for intra oral procedures. The procedure will be carried out flapless. In the study group: Atraumatic extraction The extraction socket will be evaluated for absence of any fenestration or granulation tissues

Active Comparator: deproteinized bovine as a space filling material

Granules of deproteinized bovine bone of 0.25-1.0 mm diameter were used to fill the remaining defect when the distance of the defect wall to the implant surface was > 3 mm.

Procedure: Deprotinized bovien as space filling in immidate implant placement
The selected patients will be informed of the nature of the research work and informed consent will be obtained (immediate implant placement grafting with deprotinized bovien material) Patients will be subjected to CBCT (diagnostic for upper arch). Local anesthesia will be given to the patient. Scrubbing and draping of the patient will be carried out in a standard fashion for intra oral procedures. The procedure will be carried out flapless. In the study group: Atraumatic extraction The extraction socket will be evaluated for absence of any fenestration or granulation tissues

Active Comparator: nano-hydroxyapatite alloplast as a space filling material

The patient was treated using alloplast material mixed with a nano-bone graft to fill gap between implant and freshely extracted socket

Procedure: Nano-hydroxiapatite alloplast in immidiate implant placement
The selected patients will be informed of the nature of the research work and informed consent will be obtained (immediate implant placement grafting with nano-hydroxiapatite alloplast material ) Patients will be subjected to CBCT (diagnostic for upper arch). Local anesthesia will be given to the patient. Scrubbing and draping of the patient will be carried out in a standard fashion for intra oral procedures. The procedure will be carried out flapless. In the study group: Atraumatic extraction The extraction socket will be evaluated for absence of any fenestration or granulation tissues

Outcome Measures

Primary Outcome Measures

  1. Primary stability (marginal bone loss) [3 months]

    measure device (osstell )

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adult patients with badly broken teeth in upper esthetic zone indicated for extraction

  • Both sexes.

  • No intraoral soft and hard tissue pathology

  • No systemic condition that contraindicate implant placemen

Exclusion Criteria:
  • Heavy smokers more than 20 cigarettes per day.

  • Patients with systemic disease that may affect normal healing.

  • Psychiatric problems

  • Disorders to implant are related to history of radiation therapy to the head and neck neoplasia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cairo University Cairo Egypt
2 Mohamed tarek Cairo Egypt

Sponsors and Collaborators

  • Mohamed tarek mohamed youssif omar
  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mohamed tarek mohamed youssif omar, Researcher, Cairo University
ClinicalTrials.gov Identifier:
NCT03741036
Other Study ID Numbers:
  • CEBD-CU-27-7-2018
First Posted:
Nov 14, 2018
Last Update Posted:
Nov 19, 2018
Last Verified:
Nov 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mohamed tarek mohamed youssif omar, Researcher, Cairo University

Study Results

No Results Posted as of Nov 19, 2018